Recent

% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • barristerbs barristerbs Jan 3, 2013 9:39 PM Flag

    ***BIOGEN made its decision to partner after the data was released from the FDA panel***

    BIOGEN

    Did not see a connection between ISIS' Kynamro or its delivery vehicle with "neoplasms"
    Did not agree Kynamro caused heart attacks.
    Did not agree Kynamro caused liver failure.
    Believed Kynamro assisted in preventing heart attacks.
    Believed the astounding efficacy of Kynamro in reducing Cholesterol was truthfully reported, even when used in combination with drugs for FH.

    Biogen made its decision after the FDA panel revealed its data and notes.

    You cannot explain that decision away. Biogen does not partner with companies that have unsuccessful and unpromising results, prospects and products and certainly not with a product that causes heart attacks, liver failure or cancer (neoplasms),

    Again, you cannot explain Biogen's decision so dry up.

    Sentiment: Strong Buy

 
ISIS
66.29+1.13(+1.73%)Apr 21 4:00 PMEDT